- Type / Class
- Equity / COM
- Total 13F shares
- 4,907,194
- Share change
- +4,906,194
- Total reported value
- $56,957,000
- Put/Call ratio
- 57%
- Price per share
- $11.61
- Number of holders
- 31
- Value change
- +$56,946,000
- Number of buys
- 30
Quarterly Holders Quick Answers
What is CUSIP 44486Q103?
CUSIP 44486Q103 identifies HUMA - Humacyte, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2021
Recent filing periods for CUSIP 44486Q103:
Top shareholders of HUMA - Humacyte, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
|
Former 10% Shareholder |
—
class O/S missing
|
18,312,735
|
$21,792,154 | — | 26 Aug 2021 | |
| Maven Securities LTD |
13F
|
Company |
0.23%
|
500,000
|
$5,095,000 | — | 30 Jun 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.18%
|
402,795
|
$4,104,000 | — | 30 Jun 2021 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.14%
|
300,000
|
$3,057,000 | — | 30 Jun 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.13%
|
275,000
|
$2,802,000 | — | 30 Jun 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.11%
|
240,690
|
$2,453,000 | — | 30 Jun 2021 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.1%
|
209,743
|
$2,137,000 | — | 30 Jun 2021 | |
| Eversept Partners, LP |
13F
|
Company |
0.09%
|
205,026
|
$2,089,215 | — | 30 Jun 2021 | |
| P SCHOENFELD ASSET MANAGEMENT LP |
13F
|
Company |
0.09%
|
200,000
|
$2,038,000 | — | 30 Jun 2021 | |
| Omni Partners US LLC |
13F
|
Company |
0.09%
|
191,925
|
$1,956,000 | — | 30 Jun 2021 | |
| Arena Capital Advisors, LLC- CA |
13F
|
Company |
0.05%
|
100,000
|
$1,019,000 | — | 30 Jun 2021 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
0.05%
|
100,000
|
$1,019,000 | — | 30 Jun 2021 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
55,503
|
$565,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
54,705
|
$557,000 | — | 30 Jun 2021 | |
| BERKLEY W R CORP |
13F
|
Company |
0.02%
|
41,838
|
$426,000 | — | 30 Jun 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.01%
|
30,000
|
$306,000 | — | 30 Jun 2021 | |
| Eudaimonia Partners, LLC |
13F
|
Company |
0.01%
|
26,694
|
$272,000 | — | 30 Jun 2021 | |
| HBK INVESTMENTS L P |
13F
|
Company |
0.01%
|
25,000
|
$255,000 | — | 30 Jun 2021 | |
| Exos Asset Management LLC |
13F
|
Company |
0.01%
|
15,549
|
$158,000 | — | 30 Jun 2021 | |
| PHILADELPHIA TRUST CO |
13F
|
Company |
0.01%
|
15,000
|
$153,000 | — | 30 Jun 2021 | |
| Family Manage LLC |
13F
|
Company |
0.01%
|
14,324
|
$146,000 | — | 30 Jun 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
12,550
|
$128,000 | — | 30 Jun 2021 | |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV |
13F
|
Company |
0%
|
10,000
|
$102,000 | — | 30 Jun 2021 | |
| William Edward Tente |
3/4/5
|
Chief Regulatory Officer |
—
mixed-class rows
|
54,094
mixed-class rows
|
$62,498 | — | 26 Aug 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,500
|
$15,000 | — | 30 Jun 2021 | |
| Avior Wealth Management, LLC |
13F
|
Company |
0%
|
1,000
|
$10,000 | — | 30 Jun 2021 | |
| Jeffrey Harold Lawson |
3/4/5
|
Chief Surgical Officer, Director |
—
mixed-class rows
|
9,452
mixed-class rows
|
$9,374 | — | 26 Aug 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
541
|
$6,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
500
|
$5,000 | — | 30 Jun 2021 | |
| HOWE & RUSLING INC |
13F
|
Company |
0%
|
200
|
$2,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
195
|
$2,000 | — | 30 Jun 2021 | |
| Kiernan Thomas DeAngelis |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
1,575
|
— | — | 26 Aug 2021 |
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2021
As of 30 Sep 2021,
Humacyte, Inc. - COM (HUMA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,907,194 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Diameter Capital Partners LP, Monashee Investment Management LLC, Maven Securities LTD, CVI Holdings, LLC, VANGUARD GROUP INC, LPL Financial LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and Eudaimonia Partners, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q4 2025 Across Filers
Q4 2025 holders
145
Q3 2021 holders
31
Holder diff
-114
| Investor | Q4 2025 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.